Case report avelumab-induced scleroderma in a patient with metastatic squamous cell carcinoma of the lung

HIGHLIGHTS

• who: Jefrey L. Dobrzynski and collaborators from the University of Iowa Roy Jand Lucille ACarver College of Medicine, Newton Rd, Iowa City, IA, USA have published the research work: Case Report Avelumab-Induced Scleroderma in a Patient with Metastatic Squamous Cell Carcinoma of the Lung, in the Journal: Case Reports in Dermatological Medicine of 15/Dec/2022
• what: The authors report a case of new-onset scleroderma associated with avelumab treatment in the setting of metastatic squamous cell carcinoma of the lung.

SUMMARY

Immune checkpoint inhibitors (ICIs) are immunotherapy agents efective . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.